Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (November 2024)
48 slides from Burjeel's investor presentation, November 2024
Slide 1: Burjeel Holdings
November 2024 Burjeel Holdings Leading Super-Specialty Healthcare Provider in MENA
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 02 03 Investment Strategic Case Priorities 01 Burjeel Holdings at a Glance 04 Performance Update 06 05 Appendix Guidance
Slide 4: Burjeel Holdings at a Glance
01 Burjeel Holdings at a Glance Leading Super-Specialty Healthcare Provider in MENA
Slide 5: Leading Integrated Healthcare Network in the MENA
Leading Integrated Healthcare Network in the MENA Significant scale and market presence UAE, Oman & KSA 97 19% Geographical Medical assets Inpatient market presence incl. 19 hospitals1 share in the UAE2 1,730 6+ million 1,666 Bed capacity3 Total patients4 Doctors3 Diversified portfolio of brands > 3
Slide 6: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Polyclinic Hospital 1% Pharmacies Specialty Clinic 88% 87% Dubai & Physiotherapy 1% Other 9% Northern Emirates centers Hospitals Abu Dhabi & Al Ain 10% Medical Centers 4% O
Slide 7: Business model
1 2 Business 1 Differentiating capabilities model • Level I & II Trauma Center • Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 8: Leading Cancer Care Network in the UAE
Leading Cancer Care Network in the UAE Burjeel Cancer Burjeel’s Clinical Comprehensive Institute (Burjeel Oncology Governance Oncology Medical City) Network & Research Services Cancer MDT & Clinical Guidelines Pathology, AI & Molecular Diagnostics Abu Dhabi Medical Oncology (HIPEC) Personalized Pati
Slide 9: Advancing Women & Children’s Healthcare Offering
Advancing Women & Children’s Healthcare Offering Partnering with the "Father of Fetal The UAE's largest fertility center Medicine," to provide fetal care for high- offers comprehensive treatments, risk pregnancies. First in MENA to including egg retrieval, AI embryo perform in-utero spina bifida rep
Slide 10: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in MENA
Slide 11: Unique Vision with Multiple Growth Levers
Unique Vision with Multiple Growth Levers Ramp up of Increasing Operational Geographic growth assets patient yield excellence expansion Young asset fleet, Elevate the delivery Centralization Deliver on our KSA entry with growth to be driven of high-value complex care, and digitization and explore su
Slide 12: Investment Case
03 Investment Case Leading Super-Specialty Healthcare Provider in MENA
Slide 13: Investment Case Overview
World-class super- Expanding geographically specialty care through high-return and proposition enabling low-CAPEX opportunities patient yield growth Accelerating Established leader in large, growing and resilient digitization addressable market to drive operational and medical excellence Well-invest
Slide 14: Robust Talent Investments Powering Innovation & Research Capabilities
1 World-class super-specialty care Robust Talent Investments Powering Innovation & Research Capabilities Highly skilled and growing talent pool Rare disease +720 Burjeel launched the Center for Research on Rare Blood Doctors Disorders. The center is dedicated to addressing evidence gaps and overcomi
Slide 15: Super-Specialty Care Offering Driving Patient Yields
1 World-class super-specialty care Super-Specialty Care Offering Driving Patient Yields Q3’24 Medical milestones across key complex specialties Super-specialty care performance… …drives patient yield Liver & Kidney transplants Multi-organ transplants 26 (100% success rate) Since 2024 AED 250,000 – 1
Slide 16: UAE Market Leader with a Prominent Position Across Segments
2 Established leader UAE Market Leader with a Prominent Position Across Segments Number of beds by key players1, as of December 2022 #1 inpatient platform in the UAE by private market volumes Beds excl. LTC in UAE 1,660 3 135 1,361 Beds in Oman 1,161 1,077 1,071 300 Focus on specialised and complex
Slide 17: Large, Growing and Resilient Addressable Market
2 Established leader Large, Growing and Resilient Addressable Market FY 2022 UAE & Oman & KSA market size1 $104bn Total healthcare expenditure (USD bn) 132 GCC market size2 112 $85bn UAE & Oman & KSA market size1 85 93 1.9x 19% Burjeel Holdings $27bn In-patient private market share in the 69 UAE & O
Slide 18: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception to 9M'24 AED 4.6bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints – driving reven
Slide 19: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Diverse brand portfolio and network Brands creates favourable negotiating position with insurance payers 11 Hospitals2 Insurance payers are the largest revenue 4 Hospitals 2 Hospitals Assets1 9 Medical
Slide 20: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset maturity split for hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 35% Growth – high FY 2023 Mature Burjeel Hospital, Abu Dhabi High-Growth Burjeel Me
Slide 21: Multi-Pronged Expansion Strategy to Unlock Solid Growth Potential
5 Expanding geographically Multi-Pronged Expansion Strategy to Unlock Solid Growth Potential Key region of focus – KSA Expansion strategy pillars KSA to drive our geographic expansion 1 Expanding UAE Healthcare infrastructure Zero-capex expansion into Africa, through O&M contracts Entering high pote
Slide 22: Expanding Our UAE Healthcare Infrastructure
5 Expanding geographically Expanding Our UAE Healthcare Infrastructure Launch of 1 hospital, In 2024-2025, the planned launch of one hospital, two day surgery centers, 10 primary care 2 day surgery centers, 10 clinics, and two medical centers will enable the Group to tap into new markets, attract mo
Slide 23: PhysioTherabia – Entering High Potential KSA Market
5 Expanding geographically PhysioTherabia – Entering High Potential KSA Market Highly attractive entry proposition Launched first premier physiotherapy centers 60 + Physical therapy, rehabilitation and wellness centers in 12 KSA cities in a joint venture (50:50) with Leejam Company 28 centers launch
Slide 24: Specialized Day Surgery Centers – Disruptive Innovation in Saudi Healthcare Market
5 Expanding geographically Specialized Day Surgery Centers – Disruptive Innovation in Saudi Healthcare Market Strong rationale for expansion in KSA Burjeel One – First Day Surgery Center in Riyadh • Promising macro and demographic trends o GDP growth of c.5.5% p.a. • Located in Irqah, Northwestern R
Slide 25: Ongoing Expansion of Asset-Light O&M Portfolio Drives Bottom-Line Growth
5 Expanding geographically Ongoing Expansion of Asset-Light O&M Portfolio Drives Bottom-Line Growth O&M opportunities in the UAE and MENA On-going O&M projects Al • Stakeholder: ADNOC Group (Corporate) 96,000+ Approach Dhannah • Specifications: Multi-specialty hospital in Al Dhafrah, Abu Dhabi Patie
Slide 26: Leveraging Digital Transformation to Enhance Patient Experience
6 Accelerating digitization Leveraging Digital Transformation to Enhance Patient Experience and Maximise Operational Efficiency Strategic digital initiatives Key digital achievements Patient digital channel • Mid-term key investment areas in Digital Health Mobile application • Oracle Health informat
Slide 27: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 28: Management
8 Seasoned leadership team & ESG improvements Strong Leadership with Well-Established Public Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A B N B A N B A N 70% Independent Directors
Slide 29: Strategic Pillars – ESG Framework
8 Seasoned leadership team & ESG improvements Strategic Pillars – ESG Framework System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives per y
Slide 30: FY 2023 ESG Highlights
8 Seasoned leadership team & ESG improvements FY 2023 ESG Highlights System Community Governance Environment 92% 87% 70% 7.4 kg CO e 2 Employee Inpatient Independent Direct GHG emission satisfaction score satisfaction score Directors patient intensity (-10%) 24% 73% Zero 90,949 MWh Women Outpatient
Slide 31: Sustainability Management System
8 Seasoned leadership team & ESG improvements Sustainability Management System ESG Governance on Board Level ESG Governance on Executive Level Board level Board of Directors Executive ESG Committee Chief Executive Officer Committee level NRC Committee Audit Committee Chief Finance Chief Operating Ch
Slide 32: Performance Update
04 Performance Update Leading Super-Specialty Healthcare Provider in MENA
Slide 33: Key Highlights
Key Highlights Financial Highlights Recent Business Developments Q3’24 9M’24 Expanding UAE Primary Care Network Revenue AED 1,319m AED 3,705m In line with the UAE’s vision, nine community-based primary care clinics will be launched within the next few months across Abu Dhabi, Al Ain, and Dubai. Thes
Slide 34: Delivering Strong Patient Footfall Growth On the Back of Continued Market Penetration
Delivering Strong Patient Footfall Growth On the Back of Continued Market Penetration Group inpatient footfall, k Group outpatient footfall, k % bed occupancy % OP utilisation 63% 70% 60% 66% 69% 68% 71% 69% • The Group achieved strong inpatient footfall • Outpatient footfall growth in Q3’24 growth
Slide 35: Ramping Up Revenue Along with Investments in Future Patient Growth
Ramping Up Revenue Along with Investments in Future Patient Growth Group Revenue, AED m Group EBITDA, AED m YoY EBITDA margin YoY 1,319 • Top-line growth accelerated in Q3’24, with a (reported) • Group EBITDA grew YoY in Q3’24 despite +14.1% 12% rise in patient footfall despite a high +5.1% AED 16 m
Slide 36: Burjeel Medical City Strategically Positioned to Drive High-Yield Patient Growth
5 Expanding geographically Burjeel Medical City Strategically Positioned to Drive High-Yield Patient Growth & Margin Expansion Total patients, k Revenue, AED m1 EBITDA, AED m1 % bed occupancy % EBITDA margin 50% 65% 46% 60% 16.1% 16.0% 14.7% 16.1% +19.3% +28.1% 879 +31.2% 388 737 142 303 +16.5% 108
Slide 37: Ongoing Investments in Super-Specialty & Network Expansion
Ongoing Investments in Super-Specialty & Network Expansion to Unlock Significant Growth Potential Group OPEX breakdown,1 as % of revenue Group EBITDA analysis, AED m % EBITDA margin 77.8% 79.6% 78.6% 80.1% 22.5% 20.7% 8.4% 9.3% 8.9% 9.2% +163 (46) 1.8% 2.2% 1.7% 2.0% YoY (71) Other3 +5.1% 25.1% 25.5
Slide 38: Free Cash Flow & Net Profit Performance
Free Cash Flow & Net Profit Performance Free cash flow,1 AED m Net profit analysis, AED m % FCF conversion2 % Net profit margin 64% 42% 51% 45% 49% 11.9% 11.4% 10.4% 523 497 +163 (151) YoY YoY 366 364 +9.8% +0.2% 331 137 +1 +0.3 151 (13) 137 2021 2022 2023 9M’23 9M’24 Q3’23 Q3'23 Revenue Revenue OPE
Slide 39: Maintaining a Robust Balance Sheet
Maintaining a Robust Balance Sheet AED m FY 2022 FY 2023 9M 2024 Debt maturity as of 30 September 2024 Bank balances and cash 150 170 138 Interest-bearing loans and borrowings 1,261 1,164 1,148 219 204 Bank overdrafts – – – 184 183 Bank debt1 153 1,261 1,164 1,148 131 Net debt 1,111 994 1,010 Lease
Slide 40: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in MENA
Slide 41: Mid-Term Outlook Reiterated, FY'24 Guidance Updated
Mid-Term Outlook Reiterated, FY'24 Guidance Updated FY 2024 (Expected) Mid-term (2025-2027) • UAE: +1 medical center, +2 day surgery centers, • UAE: +1 hospital in Dubai & +1 medical center Expansion +10 primary care clinics, +22 additional beds • KSA: +32 PhysioTherabia centers, • KSA: +24 PhysioTh
Slide 42: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in MENA
Slide 43: Track-record of Consistent Growth
Track-record of Consistent Growth 2007-2010 2015 2017 2019 2021 2023 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East in 2007 under LLH Launch invasive surgeries and alternative Burjeel Hospital capabilities and B
Slide 44: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘22-31E of GDP1 Healthcare expenditure as % of GDP1 +1.9% +31.9% +4% +3% +3% 4-5% 12% 19% CAGR ‘22-27E CAGR ‘22-27E of GCC UAE Oman K
Slide 45: Main Trends in Organ Transplant and Oncology Specialties in the UAE
Main Trends in Organ Transplant and Oncology Specialties in the UAE Organ transplant Oncology Total number of organ transplants performed in the UAE Total number of malignant cancer cases in UAE (k) CAGR 17-22 CAGR 2011-2022 5.0 Living 213 4.6 4.7 4.8 4.9 Deceased 184 16% 7.3% 4.0 4.1 71 3.6 3.6 3.7
Slide 46: Healthcare is a Key Focus for GCC Governments
Healthcare is a Key Focus for GCC Governments UAE initiatives Oman Health Vision 2050 KSA Vision 2030 UAE Vision 2021 To achieve sustainable funding for Some of the key initiatives health research by ensuring national in the healthcare spectrum: Providing world-class healthcare and international col
Slide 47: Group & Segment Summary
Group & Segment Summary Group financial summary Segmental financial summary2 AED millions Q3’24 Q3’23 9M’24 9M‘23 AED millions Q3’24 Q3’23 9M’24 9M‘23 Revenue 1,319 1,155 3,705 3,317 Revenue 1,319 1,155 3,705 3,317 Inventories consumed (336) (290) (941) (807) Hospitals3 1,161 1,028 3,255 2,945 Docto
Slide 48: Investor Relations
Investor Relations November 2024 Sergei Levitskii Director of Investor Relations sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 ir@burjeelholdings.com F: +971 2 2222 363 M: +971 503802383 PO Box 7400, Abu Dhabi, UAE Investor Calendar Company Website
Burjeel Holdings — Investor Presentation (November 2024) on 6ix